These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery. Yeboah KG; Akande J; Addo RT; Siwale RC; Aninkorah-Yeboah K; Siddig A J Drug Target; 2014 Jan; 22(1):34-47. PubMed ID: 23987115 [TBL] [Abstract][Full Text] [Related]
24. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Mestecky J; Michalek SM; Moldoveanu Z; Russell MW Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757 [TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. Misumi S; Masuyama M; Takamune N; Nakayama D; Mitsumata R; Matsumoto H; Urata N; Takahashi Y; Muneoka A; Sukamoto T; Fukuzaki K; Shoji S J Immunol; 2009 May; 182(10):6061-70. PubMed ID: 19414757 [TBL] [Abstract][Full Text] [Related]
26. Mucin-related epitopes distinguish M cells and enterocytes in rabbit appendix and Peyer's patches. Lelouard H; Reggio H; Mangeat P; Neutra M; Montcourrier P Infect Immun; 1999 Jan; 67(1):357-67. PubMed ID: 9864237 [TBL] [Abstract][Full Text] [Related]
27. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis. Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964 [TBL] [Abstract][Full Text] [Related]
28. Impaired mucosal immune responses in interleukin 4-targeted mice. Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021 [TBL] [Abstract][Full Text] [Related]
29. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. Shikina T; Hiroi T; Iwatani K; Jang MH; Fukuyama S; Tamura M; Kubo T; Ishikawa H; Kiyono H J Immunol; 2004 May; 172(10):6259-64. PubMed ID: 15128814 [TBL] [Abstract][Full Text] [Related]
30. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants. Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381 [TBL] [Abstract][Full Text] [Related]
31. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen. Mowat AM; Donachie AM; Jägewall S; Schön K; Löwenadler B; Dalsgaard K; Kaastrup P; Lycke N J Immunol; 2001 Sep; 167(6):3398-405. PubMed ID: 11544331 [TBL] [Abstract][Full Text] [Related]
32. Carbohydrate expression in the intestinal mucosa. Sharma R; Schumacher U Adv Anat Embryol Cell Biol; 2001; 160():III-IX, 1-91. PubMed ID: 11443891 [TBL] [Abstract][Full Text] [Related]
33. Targeting lymphocyte Peyer's patch adhesion molecule-1: a relay approach to gut immunization. McKenzie BS; Corbett AJ; Brady JL; Boyle JS; Rockman SP; Lew AM Vaccine; 2005 May; 23(28):3668-78. PubMed ID: 15882527 [TBL] [Abstract][Full Text] [Related]
34. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Jang MH; Kweon MN; Iwatani K; Yamamoto M; Terahara K; Sasakawa C; Suzuki T; Nochi T; Yokota Y; Rennert PD; Hiroi T; Tamagawa H; Iijima H; Kunisawa J; Yuki Y; Kiyono H Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6110-5. PubMed ID: 15071180 [TBL] [Abstract][Full Text] [Related]
35. Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Lelouard H; Fallet M; de Bovis B; Méresse S; Gorvel JP Gastroenterology; 2012 Mar; 142(3):592-601.e3. PubMed ID: 22155637 [TBL] [Abstract][Full Text] [Related]
36. Novel vaccination strategies for the control of mucosal infection. Husband AJ Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. Terahara K; Yoshida M; Igarashi O; Nochi T; Pontes GS; Hase K; Ohno H; Kurokawa S; Mejima M; Takayama N; Yuki Y; Lowe AW; Kiyono H J Immunol; 2008 Jun; 180(12):7840-6. PubMed ID: 18523247 [TBL] [Abstract][Full Text] [Related]
38. Arginine enhances induction of T helper 1 and T helper 2 cytokine synthesis by Peyer's patch alpha beta T cells and antigen-specific mucosal immune response. Kobayashi T; Yamamoto M; Hiroi T; McGhee J; Takeshita Y; Kiyono H Biosci Biotechnol Biochem; 1998 Dec; 62(12):2334-40. PubMed ID: 9972259 [TBL] [Abstract][Full Text] [Related]
39. A revisit of mucosal IgA immunity and oral tolerance. Fujihashi K; Kato H; van Ginkel FW; Koga T; Boyaka PN; Jackson RJ; Kato R; Hagiwara Y; Etani Y; Goma I; Fujihashi K; Kiyono H; McGhee JR Acta Odontol Scand; 2001 Oct; 59(5):301-8. PubMed ID: 11680650 [TBL] [Abstract][Full Text] [Related]
40. Regulation of mucosal IgA production in vitro by autoreactive immunoregulatory T cells from murine Peyer's patches. Kawanishi H; Mirabella S Cell Immunol; 1988 Jul; 114(2):324-35. PubMed ID: 2898979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]